Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema

NCT02471651 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: Dexamethasone intravitreal implant (0.7 mg)
DRUG: Intravitreal anti-VEGF injection

Sponsor

California Retina Consultants

Collaborators

[object Object]